What is Zacks Research’s Forecast for Clorox Q3 Earnings?

The Clorox Company (NYSE:CLX) – Zacks Research decreased their Q3 2025 earnings estimates for shares of Clorox in a research report issued to clients and investors on Monday, February 17th. Zacks Research analyst R. Department now expects that the company will earn $1.60 per share for the quarter, down from their prior forecast of $1.68. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2025 earnings at $2.14 EPS, FY2025 earnings at $7.15 EPS, Q1 2026 earnings at $1.63 EPS, Q2 2026 earnings at $1.64 EPS, Q3 2026 earnings at $1.66 EPS, FY2026 earnings at $7.12 EPS, Q1 2027 earnings at $1.74 EPS, Q2 2027 earnings at $1.76 EPS and FY2027 earnings at $7.64 EPS.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business posted $2.16 EPS.

A number of other research analysts also recently issued reports on CLX. Wells Fargo & Company raised their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Trading Up 0.1 %

Clorox stock opened at $148.11 on Wednesday. The firm’s 50-day moving average is $158.78 and its 200-day moving average is $159.71. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a market cap of $18.33 billion, a P/E ratio of 40.47, a PEG ratio of 2.53 and a beta of 0.42.

Institutional Trading of Clorox

Institutional investors have recently made changes to their positions in the stock. Brooklyn Investment Group boosted its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the period. Redwood Park Advisors LLC bought a new position in Clorox during the fourth quarter valued at approximately $26,000. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC raised its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares in the last quarter. Finally, Millstone Evans Group LLC bought a new position in Clorox during the fourth quarter valued at approximately $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.